Cite
Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease.
MLA
Gutti, Gopichand, et al. “Discovery of Triazole-Bridged Aryl Adamantane Analogs as an Intriguing Class of Multifunctional Agents for Treatment of Alzheimer’s Disease.” European Journal of Medicinal Chemistry, vol. 259, Nov. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.115670.
APA
Gutti, G., Leifeld, J., Kakarla, R., Bajad, N. G., Ganeshpurkar, A., Kumar, A., Krishnamurthy, S., Klein-Schmidt, C., Tapken, D., Hollmann, M., & Singh, S. K. (2023). Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry, 259, N.PAG. https://doi.org/10.1016/j.ejmech.2023.115670
Chicago
Gutti, Gopichand, Jennifer Leifeld, Ramakrishna Kakarla, Nilesh Gajanan Bajad, Ankit Ganeshpurkar, Ashok Kumar, Sairam Krishnamurthy, et al. 2023. “Discovery of Triazole-Bridged Aryl Adamantane Analogs as an Intriguing Class of Multifunctional Agents for Treatment of Alzheimer’s Disease.” European Journal of Medicinal Chemistry 259 (November): N.PAG. doi:10.1016/j.ejmech.2023.115670.